Orient Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.20 Cr
- Revenue Growth -79.01%
- Profit Growth -5.21%
- Ebitda
- Net Worth -22.78%
- Total Assets 91.15%
About Orient Laboratories
Orient Laboratories Private Limited (OLPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 September 1994 and has a history of 30 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹7.20 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rashmikant Shah and Kevin Shah serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24110MH1994PTC081425
-
Company No.
081425
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Sep 1994
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Orient Laboratories?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rashmikant Shah | Director | 27-Jan-2021 | Current |
Kevin Shah | Additional Director | 24-Mar-2023 | Current |
Financial Performance of Orient Laboratories.
Orient Laboratories Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 79.01% decrease. The company also saw a slight decrease in profitability, with a 5.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Orient Laboratories?
In 2020, Orient Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹72.00 M
Charges Breakdown by Lending Institutions
- Others : 5.00 Cr
- Kotak Mahindra Bank Limited : 2.20 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
31 Aug 2018 | Others | ₹5.00 Cr | Satisfied |
07 Sep 2015 | Kotak Mahindra Bank Limited | ₹2.20 Cr | Satisfied |
How Many Employees Work at Orient Laboratories?
Unlock and access historical data on people associated with Orient Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orient Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orient Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.